Indivior Pharmaceuticals, Inc. (INDV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q4 '24: 1.2B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.3B Q2 '26: 1.3B Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 400M 800M 1.2B Q4 '24: 957M Q1 '25: 932M Q2 '25: 962M Q3 '25: 951M Q4 '25: 993M Q1 '26: 1B Q2 '26: 1.1B Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

0 150M 300M 450M Q4 '24: 38M Q1 '25: 29M Q2 '25: 219M Q3 '25: 227M Q4 '25: 262M Q1 '26: 333M Q2 '26: 421M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-150M 0 150M 300M 450M Q4 '24: 7M Q1 '25: -7M Q2 '25: 108M Q3 '25: 128M Q4 '25: 209M Q1 '26: 251M Q2 '26: 355M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 90M 180M 270M Q4 '24: 231M Q1 '25: 237M Q2 '25: 210M Q3 '25: 227M Q4 '25: 246M Q1 '26: 242M Q2 '26: 240M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-160M -80M 0 80M 160M 240M Q4 '24: 36M Q1 '25: 148M Q2 '25: 218M Q3 '25: 177M Q4 '25: -27M Q1 '26: -111M Q2 '26: -40M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-210M -140M -70M 0 70M 140M 210M Q4 '24: 7M Q1 '25: 116M Q2 '25: 173M Q3 '25: 119M Q4 '25: -93M Q1 '26: -192M Q2 '26: -111M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '24: 137M Q2 '24: 135M Q3 '24: 133M Q1 '25: 125M Q2 '25: 126M Q3 '25: 129M Q1 '26: 129M Q2 '26: 124M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.00 0.00 1.00 2.00 3.00 Q4 '24: 0.05 Q1 '25: -0.02 Q2 '25: 0.84 Q3 '25: 1.01 Q4 '25: 1.64 Q1 '26: 1.95 Q2 '26: 2.79 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.